Ivonescimab (Anti-PD-1 & VEGF)
Product Specifications
CAS Number
2428381-53-5
Synonyms
AK 112, SMT 112
SKU
C00918-1mg
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Ivonescimab is a first-in-class humanized tetravalent bispecific antibody targeting PD-1 and VEGF-A, with immune checkpoint inhibitory, anti-angiogenic, and antineoplastic activities. It is being developed for the treatment of non-small cell lung cancer (NSCLC) and other solid tumors, including breast, liver, and gastric cancers. M.W 201.12 kDa
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
